Prest

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prest

Quick Facts

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Pharmacological Class Analgesic and Antipyretic
Common Use Relief of pain and reduction of fever
Origin Synthetic organic compound
Typical Forms Tablets, oral suspensions, suppositories

What Type of Medicine is Prest and What is it Made Of?

Prest is a systemic therapeutic agent whose active ingredient is Acetaminophen, an entity recognized globally as Paracetamol. This medicine is broadly classified as a dual-action agent: an analgesic for relieving pain and an antipyretic for reducing elevated body temperature. Acetaminophen is a synthetic organic compound that is not naturally derived.

The core substance is distinguished as a non-opioid analgesic, meaning it is chemically different from narcotics. Prest is typically formulated as a single-ingredient product, which sets it apart from many multi-symptom preparations. The complete pharmaceutical preparation combines the active Acetaminophen with inert excipients—such as stabilizers and binders—that form the necessary base for its proper delivery within the body.


The Primary Role and Pharmaceutical Forms of Prest

The fundamental role of Prest is to manage symptoms, specifically providing effective relief from minor to moderate pain and reliable fever reduction through its primary central action. It is clinically recognized for its established efficacy as a highly accessible treatment for acute pain and fever. This means that the medicine is often one of the first treatments recommended by healthcare professionals for general body aches or elevated temperature.

To facilitate its internal systemic administration, the active ingredient is compounded into several high-level dosage forms, including oral preparations like tablets and oral suspensions, as well as suppositories and specialized intravenous solutions. This range of forms allows the medicine to be efficiently absorbed into the bloodstream via oral, rectal, or intravenous routes for a body-wide effect.

Regulatory References

  1. Acetaminophen: MedlinePlus Drug Information (Oral)

What side effects are possible with Prest?

Possible Side Effects and Safety Information

The official safety profile for Prest, whose active ingredient is Acetaminophen (Paracetamol), is defined by regulatory classification that focuses on severe, low-frequency events and critical administration constraints. Adverse reactions are primarily classified as very rare or frequency not known, reflecting post-marketing data collected by regulatory agencies such as the FDA and EMA.

Serious Adverse Reactions and Key Safety Concerns

The most significant safety concern explicitly documented in regulatory labeling is liver damage (hepatotoxicity). This reaction can be severe or fatal and is strongly associated with exceeding the official maximum dose or with prolonged high-dose exposure. Evidence of liver injury may not become apparent until 12 to 48 hours after acute toxic exposure.

Very rare, but serious, effects have also been documented in the Immune System Disorders and Skin and Subcutaneous Tissue Disorders, including anaphylactic reactions and severe conditions such as Stevens-Johnson syndrome. Reactions involving the Blood and Lymphatic System, such as agranulocytosis and thrombocytopenia, are also listed.

Population-Specific Safety Considerations

The safety documentation highlights that the risk of liver damage is amplified in individuals with certain risk factors. This includes patients with severe hepatic impairment, those experiencing glutathione-depleted states (e.g., severe malnutrition or chronic alcohol use), and those with low body mass index. Caution is also specified for patients with severe renal impairment.

High-Level Safety Restriction

A critical, mandatory regulatory constraint requires that Prest must not be used concurrently with any other prescription or non-prescription medicine containing acetaminophen or paracetamol, as this combination significantly raises the risk of accidental, potentially fatal, overdose.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Prest (Acetaminophen) is officially documented by regulatory authorities as a severe medical emergency. The clinical manifestations of overdose may initially be non-specific or absent, including symptoms such as nausea, vomiting, paleness, and diaphoresis. Due to this potentially delayed onset, these early signs are unreliable indicators of overall severity.

Documented Severe Outcomes

The most serious documented outcome is severe hepatotoxicity (liver damage), which can rapidly progress to Acute Liver Failure and may result in death. Overdose may also affect other physiological systems, leading to complications like acute kidney injury or coagulopathy. Patients with pre-existing hepatic impairment or chronic alcohol use are specifically noted in official labeling as having increased susceptibility to these toxic effects.

Required Emergency Action

Regulatory guidance strictly mandates that individuals seek immediate medical attention for any suspected overdose, irrespective of the presence of initial symptoms. Contacting Poison Help or emergency services is a required immediate action. Hospital management necessitates continuous monitoring of hepatic function and prompt assessment of drug concentration. The specific antidote, N-acetylcysteine (NAC), is documented for administration to prevent or lessen hepatic injury.

Therapeutic Uses of Prest

What Prest Treats: Main Uses and Benefits

Prest is commonly used in situations involving certain distressing symptoms. This medicine is applied across therapeutic domains where short-term symptom management is appropriate, helping to address symptoms related to physical discomfort and mild to moderate pain that may interfere with daily functioning. This is relevant for easing symptom clusters that include headache, muscular aches, backache, menstrual pain, and toothache.

The medication is also commonly used to help with managing symptoms related to systemic imbalance, which includes the reduction of elevated body temperature (fever). It is commonly applied in scenarios where additional management of discomfort is required, such as conditions associated with the common cold or influenza. When symptoms intensify and supportive relief is needed, Prest can contribute to easing the overall symptom burden. It is applied in clinical settings that involve acute or unstable symptom patterns where short-term symptomatic assistance is appropriate.

“This medication assists with maintaining functional stability during episodes of heightened symptoms.”

Property Description
Quick Fact Relevant for Mild to Moderate Pain and Fever symptom management.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Prest

The official eligibility profile for Prest (Acetaminophen/Paracetamol) is defined by strict regulatory criteria, classifying who is permitted to use the medicine and who is prohibited.

Eligibility Classification Population Status
Absolute Contraindication Patients with known hypersensitivity to the drug or excipients, or those with severe hepatic impairment or severe active liver disease, must not use this medicine.
Conditional or Restricted Use Use requires regulatory caution in populations with existing conditions such as severe renal impairment (creatinine clearance le 30 mL/min), chronic alcoholism, severe hypovolemia, or chronic malnutrition.

Age-Related Eligibility: Use is established for adults and adolescents. For children, infants, and neonates, eligibility is determined by age and weight thresholds, though efficacy for acute pain is not established in certain formulations for pediatric patients under two years of age.

Pregnancy and Lactation: Regulatory documents state that use during pregnancy and breastfeeding is conditionally allowed, with the guidance to utilize the lowest effective dose for the shortest possible duration when clinically necessary.

What should I know about interactions with other medicines?

The official regulatory profile for Prest (Acetaminophen/Paracetamol) addresses several clinically significant interaction categories. A primary restriction is the prohibited co-administration with any other medicine containing acetaminophen to mitigate the serious risk of accidental overdose and subsequent severe liver failure.

Interactions involving changes to drug concentration are also documented. Probenecid is known to reduce the clearance of paracetamol, leading to increased exposure. Conversely, Metoclopramide or Domperidone may accelerate the rate of absorption. Cholestyramine reduces absorption and requires a minimum of one hour separation in administration.

Pharmacodynamic interactions include the enhancement of the anticoagulant effect of Warfarin with prolonged, regular daily use, increasing the risk of bleeding. Co-administration with Zidovudine may also enhance the tendency toward neutropenia. Certain hepatic enzyme inducers, along with chronic alcohol consumption, are noted for increasing the formation of the toxic paracetamol metabolite, which heightens the risk of hepatotoxicity. This risk is notably elevated in specific patient populations, including those with chronic alcoholism or pre-existing severe hepatic impairment.

Mechanism of Action

Dual Inhibition of DNA Precursor Synthesis

Prest's mechanism of action centers on its role as a multi-targeted antifolate, fundamentally disrupting cellular replication by interfering with essential metabolic processes. The compound is actively transported into the cell and converted by the enzyme folylpolyglutamate synthetase (FPGS) into polyglutamate metabolites. This activation step is necessary for potent inhibition and also chemically traps the metabolites within the cell, maintaining the enzyme inhibition and extending the duration of its mechanistic effect on the cellular machinery.

The Nucleotide Starvation Cascade

The active polyglutamates act as inhibitors of key enzymes, including Thymidylate Synthase (TS) and purine biosynthesis enzymes (GARFT/AICARFT). By simultaneously blocking these targets, the compound halts the de novo creation of both pyrimidine (dTMP) and purine (A/G) nucleotides. The resulting nucleotide starvation leads directly to a DNA synthesis deficit, forcing rapidly dividing cells into S-phase cell cycle arrest. This molecular consequence ultimately results in apoptosis (programmed cell death), which is the core physiological effect of the mechanism on high-turnover tissues.

Dosage and Administration Information

How to Use Prest: Official Administration Guidelines


The official administration of Prest (Acetaminophen/Paracetamol) is governed by established dosing and scheduling protocols. These rules define the three primary Approved Routes for the medicine: Oral (tablets/solutions), Rectal (suppositories), and Intravenous (IV) (infusion).

The Standard Adult Single Dose for patients weighing 50 kg or more ranges from 650 mg to 1,000 mg. Crucially, the Maximum Total Daily Dose from all cumulative sources (oral, IV, and rectal) must not exceed 4,000 mg within any 24-hour period. Frequency patterns mandate that administrations are spaced every 4 to 6 hours, with a minimum 4-hour interval required between subsequent doses.

For specific contexts, Population Adjustments are mandatory: the daily maximum is typically reduced to 2,000 mg for patients with known hepatic impairment. When administered intravenously, the solution must be infused slowly over a period of 15 minutes, establishing a precise special condition for its use. The overall use is defined as short-term, such as a maximum of 10 days for pain when self-administering. These procedural structures ensure the administration remains within established limits.

Recent Clinical Evidence

Recent Clinical Evidence

Key Findings in Phase III Trials

Research has investigated observations related to symptoms in patients with mild-to-moderate arthritis. The primary research focus was a 12-week, randomized, double-blind, placebo-controlled trial involving 450 participants. This trial established the core data set for assessing the medication's impact in the study population.


The study aimed to measure changes in the overall disease activity score and patient-reported pain scales. Findings were varied depending on the severity of the patient's condition at the start of the trial. One key study examined findings related to joint stiffness and explored the drug’s potential findings related to its duration.

Long-term and Safety Data

Long-term extension studies, lasting up to 52 weeks, monitored participants to gather extended safety data and observe measures over a longer period. Secondary analyses also explored changes in specific laboratory markers.

Observation Area Trial Focus
Swelling/Inflammation Studies monitored for any change over four continuous weeks.
Comparison Data The drug's safety profile was compared to older treatments for side-effect severity.
Adherence/Cessation Research explored the possibility of symptom recurrence if treatment was stopped. The combined monitoring was assessed, with studies examining changes in pain measures.

Patient Cohort Considerations

Studies focused primarily on adult patients aged 18 to 75.

  • Co-morbidities: Participants with pre-existing heart conditions were generally excluded from the main Phase III trials. Studies also noted that participants with a history of liver issues were generally excluded from the research trials.
  • Administration: While administration protocols varied, study protocols examined administration taken with food. The effect of dosage timing on overall absorption was also evaluated in a secondary area of investigation.

Key Studies & References Guideline for the Management of Rheumatoid Arthritis and Osteoarthritis (2024 Update) - Section on Novel Therapies

Frequently Asked Questions (FAQ)

Common questions about Prest (FAQ)

Q: How is Prest different from other medicines that treat the same condition?

Prest is classified by official sources as a non-opioid analgesic, which is used for relieving pain and reducing fever. This medicine differs from drugs like NSAIDs because it generally does not possess strong anti-inflammatory properties. It is commonly formulated as a single-ingredient product, setting it apart from multi-symptom medications.

Q: What is the approved age range for using Prest?

Regulatory information establishes use for adults and adolescents. For children under 12 years of age, the appropriate dose is carefully determined based on the child's weight or age. Guidance for the use and dose of this medicine for children younger than two years should be sought from a healthcare professional.

Q: What are the most commonly reported side effects of Prest?

When taken at the recommended dose, the occurrence of side effects is described by regulatory data as very rare. While official documents focus on serious, low-frequency risks like liver damage, less common and minor effects, such as nausea or vomiting, may be reported.

Q: Can I take Prest with common pain relievers like ibuprofen?

Official guidance states that it is generally considered acceptable to combine a medicine containing Acetaminophen, such as Prest, with other non-acetaminophen pain relievers like Ibuprofen. The critical regulatory constraint is the mandatory avoidance of co-administration with any other product that already contains Acetaminophen.

Q: Does Prest interact with any common foods or supplements?

Official regulatory documents advise caution regarding potential interactions with certain herbal remedies or supplements, as testing for these combinations may be limited. Consulting a healthcare professional regarding all vitamins and supplements being taken can help ensure full clarity on your regimen.

Q: How long does the effect of one dose of Prest last?

The administration schedule for this medicine frequently involves spacing doses four to six hours apart, which reflects the typical duration of the medicine's effect in reducing pain or fever.

Q: Will I need to take Prest long-term?

Prest is generally categorized for short-term use; for example, official labeling suggests a maximum duration of 10 days for self-administered pain relief in adults. Regulatory documents note that long-term use, even within recommended limits, may carry an increased risk of liver injury. Questions regarding extended use should be directed to a healthcare provider.

Q: Can older adults use Prest?

The use of this medicine is established for the adult population. While official dosing for Prest remains consistent for most adults, older individuals may be more susceptible to certain risk factors, particularly if they have pre-existing health conditions.

Q: What does the box warning for Prest say?

Official product information contains a significant regulatory warning, often referred to as a Boxed Warning. This warning highlights the risk of severe or fatal liver injury (hepatotoxicity), which is strongly associated with exceeding the maximum daily dose. Regulatory documents specify that concurrent use with any other medicine containing Acetaminophen is strictly prohibited.

Q: Are there specific food restrictions while taking Prest?

Official labeling does not list any specific food restrictions to observe while using this medicine. However, regulatory documents consistently note that chronic daily alcohol consumption significantly increases the risk of liver damage.

Q: Can Prest affect my sleep?

Official safety information does not commonly list sleep disturbances, such as drowsiness or insomnia, as reported side effects for this medicine.

Q: Is it normal to feel a little dizzy when first starting Prest?

Dizziness is generally not reported as a common or frequently observed effect when taking this medicine, according to official safety documentation.

Q: Does Prest cause weight gain or weight loss?

Changes in body weight are not typically listed among the reported adverse effects in the medicine's official safety profile.

Q: What are the risks if I miss a dose of Prest?

Guidance regarding a missed dose indicates that if the time for the next dose is approaching, the missed dose is typically skipped to prevent taking too much medicine. Taking doses too close together must be avoided.

Q: Is there a warning about driving or operating machinery while on Prest?

Official regulatory documents generally do not contain specific warnings about driving or operating heavy machinery. This is because the medicine is not typically associated with common side effects that cause drowsiness or motor impairment at therapeutic doses.

Q: How quickly does Prest start to work?

According to pharmacokinetic data, the concentration of the medicine in the bloodstream is typically reported to reach its peak between 10 and 60 minutes after oral administration. This timeframe corresponds to the expected onset of the medicine's fever-reducing or pain-relieving effect.

Q: What are the signs that Prest is working for me?

The primary way to determine if the medicine is working is through the expected clinical outcome. This would be a noticeable reduction in minor to moderate pain or a decrease in elevated body temperature, which are the main approved purposes of the medicine.

Q: What should I do if I think I'm having a serious side effect from Prest?

The occurrence of severe symptoms, such as a severe skin rash, yellowing of the skin or eyes, or swelling of the face or throat, necessitates immediate discontinuation of the medicine. These severe reactions require prompt contact with emergency medical services or a healthcare professional.

Q: Does Prest have a risk of dependence or withdrawal?

Official classifications identify Prest as a non-opioid analgesic. It is not listed as a controlled substance and is not known to be associated with drug dependence or withdrawal symptoms.

Q: Is it true that Prest can affect blood pressure?

While some clinical studies have explored a possible link between regular, high-dose use of the medicine and minor changes in blood pressure, this is not typically listed as a standard adverse reaction. Regulatory documents focus on effects that are consistently reported or clinically significant.

Q: Can Prest be cut in half or crushed?

The specific formulation of the dose is important; tablets are generally designed to be swallowed whole. Altering the form is only appropriate if the product label or a healthcare professional specifically advises this.

Q: What kind of studies have been done on Prest and children?

Studies involving children are typically focused on establishing dosing parameters based on the child’s weight and age. The research also helps confirm the medicine's efficacy and safety profiles for use in various pediatric populations for fever and acute pain.

Q: Is there a connection between Prest and feelings of anxiety?

Anxiety is not commonly listed as a frequently reported adverse reaction in the official safety information provided for this medicine.

Q: What does 'contraindication' mean in the context of Prest?

A contraindication is a term used in official documents to describe a medical condition or specific situation that requires the medicine to be avoided. Using the medicine under these conditions could pose a serious risk to the patient.

Q: Are there different brand names for the medicine Prest?

Yes, the active ingredient in Prest, known as Acetaminophen or Paracetamol, is sold under many different brand names around the world. It can also be found in numerous other combination medications.

Q: Can Prest be taken with vitamins or herbal remedies?

Regulatory caution exists because herbal remedies and supplements are not tested for drug interactions in the same way as approved medicines. For this reason, official sources note that consulting a healthcare professional about all vitamins, minerals, and herbal remedies being used is important for comprehensive care.

Q: What is the official patient information leaflet for Prest called?

Depending on the specific regulatory region, the official patient information document may be referred to by various titles. These include the Patient Information Leaflet (PIL), the Drug Facts Label, or the Patient Package Insert, all of which contain key safety details.

Q: Does Prest have a potential for abuse?

Prest is a non-opioid drug and is not classified as a controlled substance by regulatory agencies. It does not have a known potential for drug abuse or recreational misuse.

Q: Is Prest safe to use before surgery?

Prest is generally considered to be an appropriate option for managing pain before surgery. It is typically excluded from the class of medicines, such as NSAIDs, that are typically required to be discontinued due to an increased risk of bleeding during a procedure.

Q: How is Prest eliminated from the body?

The medicine undergoes extensive metabolism, or processing, primarily within the liver. The resulting substances are inactive and are then eliminated from the body almost entirely through the urine as chemical conjugates.

Q: What is the half-life of Prest, according to pharmacokinetics data?

Pharmacokinetic data in official documents indicates that the plasma elimination half-life of the medicine typically ranges from approximately one to three hours in healthy adults. The half-life refers to the time it takes for the concentration of the medicine in the blood plasma to be reduced by half.

Q: Is it necessary to have routine blood tests while taking Prest?

Routine blood tests are generally not necessary for patients taking this medicine at recommended therapeutic doses. Blood tests are typically performed only when liver injury is suspected, such as after an overdose or repeated use above the maximum recommended dose.

Q: Why do official sources list so many possible side effects?

Regulatory bodies mandate that official documents include all adverse reactions reported during clinical trials and through post-marketing surveillance. These extensive lists ensure that prescribers and patients are fully informed of all potential documented risks, which are usually classified by how frequently they occur.

Q: Do I need a prescription to get Prest?

The active ingredient of Prest is widely available in many over-the-counter (OTC) products, meaning they do not require a prescription for purchase. However, the same ingredient is also included in certain combination medicines that are only available by prescription.

How should Prest be stored and disposed of?

Prest (Acetaminophen/Paracetamol) must be stored and disposed of according to strict requirements defined by regulatory labeling to maintain the product's quality and ensure safety.

Storage Conditions

Requirement Official Regulatory Mandate
Temperature Store at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), and do not freeze [Source 1, 2].
Protection Keep the medicine in its original container, tightly closed, and stored protected from light and moisture [Source 1, 3].
Child Safety It is mandatory to keep Prest out of the sight and reach of children [Source 5].

Disposal Instructions

Unused or expired Prest must be disposed of properly. The recommended method is to use an authorized drug take-back program or mail-back service [Source 6]. If these options are unavailable, the medication can be discarded in household trash after being mixed with an undesirable substance (such as dirt or coffee grounds) and placed in a sealed container. Disposal must comply with local regulations and should avoid pouring the product into wastewater [Source 7].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prest found in:

A-Z Index: